ACM
MEDP icon

American Capital Management’s Medpace MEDP Stock Holding History

American Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Sell
210,217
-7,730
-4% -$3.57M 4.99% 3
2026
Q1 		$105M Sell
217,947
-6,427
-3% -$3.29M 5.62% 1
2025
Q4 		$126M Sell
224,374
-24,383
-10% -$13.8M 5.56% 3
2025
Q3 		$128M Sell
248,757
-16,674
-6% -$7.28M 5.1% 4
2025
Q2 		$83.3M Sell
265,431
-59,380
-18% -$17.8M 3.46% 7
2025
Q1 		$99M Sell
324,811
-4,624
-1% -$1.56M 4.03% 5
2024
Q4 		$109M Sell
329,435
-51,211
-13% -$17.4M 4.07% 5
2024
Q3 		$127M Buy
380,646
+9,592
+3% +$3.64M 4.15% 5
2024
Q2 		$153M Sell
371,054
-8,107
-2% -$3.21M 5.12% 4
2024
Q1 		$153M Sell
379,161
-15,959
-4% -$5.61M 4.91% 6
2023
Q4 		$121M Sell
395,120
-25,800
-6% -$6.96M 4.14% 8
2023
Q3 		$102M Sell
420,920
-7,854
-2% -$2.01M 3.93% 8
2023
Q2 		$103M Buy
428,774
+1,037
+0.2% +$215K 3.58% 8
2023
Q1 		$80.4M Sell
427,737
-1,926
-0.4% -$398K 2.83% 12
2022
Q4 		$91.3M Sell
429,663
-34,490
-7% -$6.89M 3.57% 10
2022
Q3 		$73M Sell
464,153
-799
-0.2% -$127K 2.88% 12
2022
Q2 		$69.6M Buy
464,952
+40,401
+10% +$5.85M 2.61% 13
2022
Q1 		$69.5M Buy
424,551
+28,198
+7% +$4.65M 2.05% 20
2021
Q4 		$86.3M Buy
396,353
+9,979
+3% +$2.09M 2.21% 17
2021
Q3 		$73.1M Buy
386,374
+28,794
+8% +$5.25M 1.96% 17
2021
Q2 		$63.2M Buy
357,580
+48,830
+16% +$8.43M 1.77% 21
2021
Q1 		$50.6M Buy
308,750
+24,418
+9% +$3.73M 1.53% 25
2020
Q4 		$39.6M Buy
284,332
+14,169
+5% +$1.79M 1.18% 29
2020
Q3 		$30.2M Buy
270,163
+58,677
+28% +$6.78M 1.11% 30
2020
Q2 		$19.7M Buy
211,486
+52,585
+33% +$4.47M 0.72% 32
2020
Q1 		$11.7M Buy
+158,901
New +$13.8M 0.57% 36

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

American Capital Management's MEDP Position: Q2 2026 in Review

American Capital Management reduced its Medpace (MEDP) stake by 3.5% in Q2 2026, selling an estimated $3.57M and leaving 210,217 shares worth $111M. The position accounts for 4.99% of the portfolio, ranked #3.

American Capital Management first reported a position in MEDP in Q1 2020 and has held it in 26 quarters since. The position peaked at $153M in Q1 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • American Capital Management held 210,217 shares of Medpace worth $111M as of Q2 2026.
  • American Capital Management sold 7,730 Medpace shares in Q2 2026, an estimated $3.57M.
  • Medpace made up 4.99% of American Capital Management's portfolio in Q2 2026, its #3 holding.
  • American Capital Management first reported a position in Medpace in Q1 2020 and has held it in 26 quarters since.
  • American Capital Management's Medpace position peaked at $153M in Q1 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.